Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

Targeting quorum sensing by designing azoline derivatives to inhibit the N-hexanoyl homoserine lactone-receptor CviR: Synthesis as well as biological and theoretical evaluations.

Bucio-Cano A, Reyes-Arellano A, Correa-Basurto J, Bello M, Torres-Jaramillo J, Salgado-Zamora H, Curiel-Quesada E, Peralta-Cruz J, Avila-Sorrosa A.

Bioorg Med Chem. 2015 Dec 15;23(24):7565-77. doi: 10.1016/j.bmc.2015.10.046. Epub 2015 Nov 2.

2.

Synthesis, primary photophysical and antibacterial properties of naphthyl ester cinoxacin and nalidixic acid derivatives.

Vargas F, Zoltan T, Rivas C, Ramirez A, Cordero T, Díaz Y, Izzo C, Cárdenas YM, López V, Gómez L, Ortega J, Fuentes A.

J Photochem Photobiol B. 2008 Aug 21;92(2):83-90. doi: 10.1016/j.jphotobiol.2008.05.001. Epub 2008 May 13.

PMID:
18562206
3.
4.

Endosymbiotic alga from green hydra under the influence of cinoxacin.

Kovacević G, Kalafatić M, Ljubesić N.

Folia Microbiol (Praha). 2005;50(3):205-8.

PMID:
16295658
5.

Corneal and scleral permeability of quinolones--a pharmacokinetics study.

Tai MC, Lu DW, Chiang CH.

J Ocul Pharmacol Ther. 2003 Dec;19(6):547-54.

PMID:
14733712
6.

Interactions of metal ions with two quinolone antimicrobial agents (cinoxacin and ciprofloxacin). Spectroscopic and X-ray structural characterization. Antibacterial studies.

López-Gresa MP, Ortiz R, Perelló L, Latorre J, Liu-González M, García-Granda S, Pérez-Priede M, Cantón E.

J Inorg Biochem. 2002 Sep 30;92(1):65-74.

PMID:
12230989
7.
8.

Synthesis, characterization, and crystal structure of [Cu(cinoxacinate)2].2H2O complex: a square-planar CuO4 chromophore. Antibacterial studies.

Ruiz M, Perelló L, Ortiz R, Castiñeiras A, Maichle-Mössmer C, Cantón E.

J Inorg Biochem. 1995 Sep;59(4):801-10.

PMID:
7595467
9.

Effect of nalidixic acid, pipemidic acid and cinoxacin on chondrocyte metabolism in explants of articular cartilage.

Brand HS, van Kampen GP, van der Korst JK.

Clin Exp Rheumatol. 1990 Jul-Aug;8(4):393-5.

PMID:
2397627
10.

Improved susceptibilities to cinoxacin and other antimicrobial agents of some Providencia species re-identified on the basis of fermentation of polyhydric alcohols.

Cornaglia G, Mistretta M, Dainelli B, Satta G.

J Chemother. 1989 Jul;1(4 Suppl):29-32. No abstract available.

PMID:
16312291
11.

[Comparative evaluation of norfloxacin and cinoxacin in the therapy of complicated infections of the urinary tract].

Cristiano P, Morelli G, Simioli F, Iovene MR, Della Vittoria Scarpati M, Manguso L.

Minerva Med. 1989 Apr;80(4):393-5. Italian.

PMID:
2657499
12.

Absence of cinoxacin-induced DNA fragmentation and mutations in the rat granuloma pouch.

Pino A, Maura A, Grillo P.

Environ Mol Mutagen. 1989;13(2):112-5.

PMID:
2917551
13.
14.

Susceptibility of Bordetella pertussis to five quinolone antimicrobic drugs.

Appleman ME, Hadfield TL, Gaines JK, Winn RE.

Diagn Microbiol Infect Dis. 1987 Oct;8(2):131-3.

PMID:
2892608
15.

[Cinoxacin reduces the diffusion of plasmid resistance to antibiotics].

Schito G, Debbia E.

Recenti Prog Med. 1987 Jun;78(6):312-3. Italian. No abstract available.

PMID:
3659558
16.

[Clinical study of cinoxacin in acute simple cystitis].

Inaba T, Watanabe H, Ohe H.

Hinyokika Kiyo. 1986 Feb;32(2):293-6. Japanese.

17.
18.

[In vitro comparative activity of norfloxacin in the comparison of pathogenic bacteria of the urinary tract].

Carlone NA, Cuffini AM, Tullio V, Savoia D, Cavallo GP.

G Batteriol Virol Immunol. 1986 Jan-Jun;79(1-6):85-97. Italian.

PMID:
3479370
19.

[Gyrase inhibitor].

Forth W.

Klin Wochenschr. 1985 Oct 1;63(19):1036-9. German. No abstract available.

PMID:
2999503
20.

Susceptibility of Bordetella pertussis to doxycycline, cinoxacin, nalidixic acid, norfloxacin, imipenem, mecillinam and rifampicin.

Zackrisson G, Brorson JE, Björnegård B, Trollfors B.

J Antimicrob Chemother. 1985 May;15(5):629-32.

PMID:
2861190

Supplemental Content

Loading ...
Support Center